Results 1 - 25 from 182 for "iasi"
-
Genpact Romania Continues Investment In Iasi By Opening New Delivery Center
04.08.2025
Outsourcing service provider Genpact Romania, the local subsidiary of the Indian group by the same name, continues investment in Iasi by opening a new delivery center, its officials said in a more
-
APAN Group Invests EUR5M In Porsche Service Center In Iasi
04.02.2025
The APAN Group, one of the largest car dealers in Moldavia, has invested EUR5 million in a Porsche service facility in Iasi, the third in the country, after Bucharest and Timisoara. more
-
Iulius Group Invests EUR80 In Reconfiguring Palas Complex In Central Iasi
03.25.2025
The Iulius Group will begin an extensive reconfiguration project at its Palas Iasi mixed-use complex, using a concept designed by Foster+ Partners, the first project by the famous international more
-
Antibiotice Iasi Wants to Distribute RON13.8M Worth of Dividends
03.13.2025
Romanian drug manufacturer Antibiotice Iasi has proposed the distribution of RON13.8 million worth of dividends from the 2024 net profit reported on the basis of annual audited financial statements, more
-
Antibiotice Iasi 2024 Revenues Up 8% To RON693M, Net Profit Rises 23% To RON99M
02.26.2025
Romanian drug manufacturer Antibiotice Iasi in 2024 registered total revenues worth RON693 million, up 8%, and RON99 million net profit, 23% above the 2023 level. more
-
ELI Parks Further Expands ELI Park Iasi
02.19.2025
ELI Parks, one of the most dynamic developers on Romania logistics and industrial market, has leased out phase one of ELI Park Iasi, which fills a 21,000-sqm area, and will further expand the project more
-
Constructii Erbasu and Conest Set to Build Iasi Respiratory Diseases Hospital for EUR84.6M
02.19.2025
Constructii Erbasu, a company owned by Erbasu family, in association with Iasi-based Conest, controlled by Viorel Cozma, have won a contract of around RON421.1 million (EUR84.6 million), VAT not more
-
Iulius Bets Expansion Of Palas Iasi And Constant Project
01.27.2025
Developer Iulius is betting on the expansion of the Palas Iasi and on the start of its project in Constanta. more
-
Uniprest Instal Signs Lease Contract For 3,000 Sqm In ELI Park Iasi
01.22.2025
Uniprest Instal, a wholesaler of heating installations based in Targu-Mures and controlled by Dutch group Rensa, has signed a lease contract for 3,000 square meters within ELI Park Iasi. more
-
Constructii Hidrotehnice Iasi Signs Contract Worth RON23M, Double Its Market Capitalization
11.28.2024
Constructii Hidrotehnice Iasi (stock symbol: CHIA), specialized in hydrotechnics, has announced in a stock market report on Thursday, Nov 28, the signing of a contract worth RON23.13 million, which is more
-
Dr. Max Group Leases almost 12,000 Sqms of Logistic Spaces and Offices in ELI Park Iasi
10.21.2024
Dr. Max, a major player on Romania’s pharma market, has signed a leasing contract for 11,800 square meters in ELI Park Iasi, a project part of the portfolio of ELI Parks, one of the most dynamic more
-
Antibiotice Iasi Aims to Invest RON850M by 2030
10.02.2024
Romanian drug manufacturer Antibiotice Iasi has a RON850 million investment plan until 2030, covered through a funding mix, made up of cohesion funds, state aid, PNRR funds and EIB loan, stated more
-
Startup Munch Expands To Iasi
09.17.2024
Hungary-based startup Munch, which provides an application designed to help curb food waste and entered the Romanian market this spring, is expanding operations in the country to Iasi, where it more
-
Chimcomplex Bids To Take Over Heating Concession In Iasi
08.26.2024
Chemical producer and supplier Chimcomp0lex Borzesti (CRC.RO), which owns two industrial sites in Onesti and Ramnicu Valcea and is one of the largest entrepreneurial businesses in Romania, has more
-
Investment Fund Oresa Industra Aims to Double Its Iasi Logistics Area
08.19.2024
Oresa Industra currently has a 77,000-sqm portfolio concentrated in two logistic projects, a 35,000-sqm project in Iasi, and a 42,000-sqm one in Arad. more
-
Antibiotice Iasi Reports RON74M Net Profit For H1/2024, Up 20% YoY
08.14.2024
Romanian-owned drug manufacturer Antibiotice Iasi (stock symbol: ATB) ended the first half of 2024 with net profit of RON74 million, up 20% on the year, while its revenue rose by 8% to RON380 million, more
-
University Of Medicine And Pharmacy Of Iasi Gets EUR35.4M Loan From EIB
06.25.2024
Romania’s Grigore T. Popa University of Medicine and Pharmacy of Iasi (UMF Iasi) is borrowing EUR35.4 milion from the European Investment Bank (EIB) to refurbish and upgrade campus buildings. more
-
Affidea Invests EUR15M In Radiotherapy Center In Iasi
05.21.2024
Affidea, the largest player in the medical imaging services market in Romania, has completed the acquisition of MedEuropa radiotherapy centers, a deal announced in March 2024. The first step for the more
-
Antibiotice Iasi Records 13% Revenue Growth in Q1/2024. Net Profit Climbs 68%
05.15.2024
Antibiotice Iasi, the largest Romanian-owned drug manufacturer, saw revenues reach an overall RON192.5 million level, 13% higher than in the year-earlier period. more
-
Antibiotice Iasi Eyes RON850M Investments by 2030
04.30.2024
Antibiotice Iasi, the largest Romanian-held drug maker, has a total RON850 million investment plan between 2023-2030 to reach RON1 billion turnover at the end of this period. more
-
STRABAG Completes Construction Of T4 Terminal At Iasi International Airport Within EUR65.6M Project
03.29.2024
STRABAG, the European technology group for construction services, has completed the T4 terminal of the Iasi International Airport. more
-
Antibiotice Iasi Commissions 2.5 MW Photovoltaic Plant
03.28.2024
Pharma manufacturer Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, with total investments in the project amounting to RON11.8 million, of which RON4.07 million were granted by the more
-
Mobexpert Leases 1,400 Sqms of Warehousing Spaces in Oresa Industra Park of Iasi
03.26.2024
Furniture retailer Mobexpert is expanding its logistics and warehousing operations by leasing 1,400 square meters in logistic park Oresa Industra Park of Iasi owned by Oresa Industra, the real estate more
-
Antibiotice Iasi Wants to Cross RON100M Profit Threshold in 2024
03.25.2024
Antibiotice Iasi, the biggest Romanian-held drug manufacturer, wants to reach RON104 million net profit in 2024, up 28% from 2023, in line with its income and expenses budget. more
-
Antibiotice Iasi Seeks To Pay Dividends Of RON31M From 2023 Profit
03.14.2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) is summoning its shareholders to approve, among others, the distribution of RON31 million from the company's 2023 profit under the form of more